52 research outputs found
Diagnosis and treatment of thyroid cancer in children in the multicenter analysis in Poland for PPGGL
Introduction: Differentiated thyroid carcinoma (DTC) in
children presents different biological behavior in comparison
to adults. Authors presents preliminary results of multicenter
analysis concerning incidence, diagnostics and treatment
of DTC in children.
Material and methods: The study is a retrospective analysis
of 107 pediatric patients from 14 academic centers based
on the data from 2000 to 2005 obtained by questionnaire in
hospitals involved in the treatment of DTC in children.
Results: Papillary thyroid cancer was diagnosed in 83 children,
follicular thyroid cancer in 10 children and medullary
thyroid cancer in 14 children. Incidence of DTC in children
was estimated between 18 and 23 cases per year. The biggest
group of patients consisted of children between 11 and
15 years of age, with girls to boys ratio 3.3 : 1. Clinically DTC
in children presented most often as solitary thyroid nodule.
Cervical lymphadenopathy was observed in 42% of patients.
Intraoperative verification indicated metastatic nodes
in 50% of children. Low stage DTC predominated (T1
in 36% and T2 in 26% of children). One step surgery was performed in 65% of children with DTC, two step surgery
in 25% of patients. I131 therapy was undertaken in 80% of
children. Lung metastases were indicated in post therapeutic
studies in 14% of children with DTC. Prophylactic thyroidectomies
were performed in 79% of children in the group
of patients with MTC and RET gene mutations.
Conclusions: The necessity of introduction of unified therapeutic
standard in children with DTC in Poland is underlined.Wstęp: Zróżnicowane raki tarczycy (DTC, differentiated thyroid
carcinoma) występują u dzieci rzadko. Większość przypadków
wykrywanych jest w wieku 11-17 lat. W odróżnieniu
od dorosłych DTC u dzieci prezentują odmienne zachowanie
biologiczne. Mała liczba przypadków DTC
w poszczególnych ośrodkach oraz względnie łagodny ich
przebieg utrudniają ocenę występowania i leczenia DTC
u dzieci w Polsce, uzależniając ją od wysiłków włożonych
w uzyskanie rzetelnych danych. Autorzy przedstawiają
wstępne wyniki analizy wieloośrodkowej dotyczące występowania,
diagnostyki i leczenia DTC u dzieci.
Materiał i metody: Podjęte badania są retrospektywną analizą
obejmującą lata 2000-2005, opartą na danych z historii
chorób uzyskanych z ankiet rozesłanych do ośrodków dla
dzieci i dorosłych podejmujących leczenie DTC. Do analizy
zgłoszono 107 pacjentów z 14 ośrodków akademickich
w Polsce. Analizie poddano wiek i płeć dzieci z DTC, wielkość
i lokalizację zmian w tarczycy, sposoby rozpoznawania
DTC, rodzaje i zakres wykonywanych zabiegów operacyjnych
oraz leczenie uzupełniające izotopem J131.
Wyniki: Raka brodawkowatego stwierdzono u 83 dzieci,
pęcherzykowego u 10 dzieci, a rdzeniastego u 14 dzieci. Częstość
występowania DTC u dzieci w Polsce wahała się między
18 a 23 przypadkami rocznie. W województwach: mazowieckim
i połączonych wielkopolskim i lubuskim wykazano
w okresie 2000-2005 wyższą (24 i 25) częstość występowania
DTC, w pozostałych województwach wykazywano
od 2 do 10 przypadków DTC. Największą grupę pacjentów
stanowiły dzieci w wieku 11-15 lat, a stosunek dziewcząt do chłopców wynosił 3,3 : 1. Klinicznie DTC prezentowały
się najczęściej jako pojedyncze guzki tarczycy. Limfadenopatię
szyjną w badaniu klinicznym stwierdzono
u 42% pacjentów, a śródoperacyjnie u 50% dzieci. U większości
pacjentów dominowały niższe stopnie zaawansowania
DTC (T1 u 36% i T2 u 26% dzieci). Operacje jednoetapowe
wykonano u 65% dzieci, operacje dwuetapowe u 25%
dzieci, a profilaktyczne tyreoidektomie u 79% dzieci z grupy
pacjentów z rakiem rdzeniastym tarczycy (MTC, medullary
thyroid cancinoma) i mutacją genu Ret. Leczenie izotopowe
J131 podjęto u 80% dzieci. Przerzuty do płuc w scyntygrafii
poterapeutycznej wykazano u 14% dzieci z DTC.
Wnioski: We wnioskach podkreśla się konieczność wdrożenia
na terenie całego kraju ujednoliconego i ocenianego
na podstawie obiektywnych przesłanek sposobu postępowania
z dziećmi z DTC
Hydrothermal Synthesis of Delafossite-Type Oxides
The syntheses of copper and silver delafossite-type oxides from their constituent binary metal oxides, oxide hydroxides and hydroxides, by low temperature (<210 °C) and low pressure (<20 atm) hydrothermal reactions are described. Particular emphasis is placed on how the acid-base character of a constituent oxide determines its solubility and therefore whether a particular delafossite-type oxide can be synthesized, a strategy utilized by geologists and mineralogists to understand the conditions necessary for the synthesis of various minerals. Thus, the geochemical and corrosion science literature are shown to be useful in understanding the reaction conditions required for the syntheses of delafossite-type oxides and the relationship between reactant metal oxide acid-base character, solubility, aqueous speciation, and product
formation. Manipulation of the key parameters, temperature, pressure, pH, and reactant solubility, results in broad families of phase-pure delafossite-type oxides in moderate to high yields for copper, CuBO2 (B) Al, Sc, Cr, Mn, Fe, Co, Ga, and Rh), and silver, AgBO2 (B ) Al, Sc, Fe, Co, Ni, Ga, Rh, In, and Tl)
Viremic relapse after HIV-1 remission in a perinatally infected child
We previously reported the remission of human immunodeficiency virus type 1 (HIV-1) in a perinatally infected child — the “Mississippi Child.” After receiving antiretroviral therapy (ART) between 30 hours and 18 months of age, this child had persistently undetectable plasma HIV-1 viremia for 12 months in the absence of HIV-1–specific immune responses. At the time of the initial case report, it was uncertain whether HIV-1 reservoirs were established that could lead to rebound viremia
Use of Dried-Blood-Spot Samples and In-House Assays To Identify Antiretroviral Drug Resistance in HIV-Infected Children in Resource-Constrained Settings ▿
Monitoring HIV drug resistance is an important component of the World Health Organization's global HIV program. HIV drug resistance testing is optimal with commercially available clinically validated test kits using plasma; however, that type of testing may not be feasible or affordable in resource-constrained settings. HIV genotyping from dried blood spots (DBS) with noncommercial (in-house) assays may facilitate the capture of HIV drug resistance outcomes in resource-constrained settings but has had varying rates of success. With in-house assays for HIV reverse transcriptase, we evaluated the yield of genotyping DBS samples collected from HIV-infected children who were enrolled in two clinical trials conducted in sub-Saharan Africa (median HIV viral load, 5.88 log10 HIV RNA copies/ml; range, 4.04 to 6.99). Overall, HIV genotypes were obtained for 94 (89.5%) of 105 samples tested (95% and 84% from clinical trials #1 and #2, respectively); however, successful analysis of 15 (16.1%) of the 94 samples required repeat testing using a different set of primers on previously synthesized cDNA. The yield of genotyping was lower on the DBS that were stored suboptimally from clinical trial #2 (56% versus 88% for optimally stored). Concordance with plasma genotypes derived using a clinically validated, commercial kit-based assay (ViroSeq HIV-1 genotyping system) was also assessed in a subset of children with paired testing. For 34 samples with paired DBS and plasma genotypes, there was 100% concordance for major drug resistance mutations. DBS genotyping using in-house assays provides an alternative for antiretroviral drug resistance testing in children in resource-constrained regions but may require region-specific optimization before widespread use
Development of a Microfluidic Setup to Study the Corrosion Product Deposition in Accelerated Flow Regions
Corrosion: Reproducing deposition in nuclear power plants A simplified micro-fluidic system can successfully emulate corrosion products deposition in nuclear reactor water circuits. A team led by Fabio Scenini at the University of Manchester in the U.K. used a stainless steel disc with a micro-orifice and a micro-fluidic cell to build a system recreating the accelerated flows of an operating power plant. They monitored the pressure drop and build-up rate of corrosion products in real time, showing that more efficient setup reproduced corrosion seen under plant conditions, and that spallation of built-up oxide was a consequence of competition between its complex hydrodynamic and electrokinetic preferential deposition and its removal at high velocities. When adding lithium to the water, corrosion oxide formation was limited. Applying this methodology may help us better understand corrosion in nuclear reactors
Development of a microfluidic setup to study the corrosion product deposition in accelerated flow regions
Application of EPR Spectroscopy for Examination of Free Radical Formation in Thermally Sterilized Betamethasone, Clobetasol, and Dexamethasone
Recommended from our members
Human Immunodeficiency Virus Type 1 DNA Decay Dynamics With Early, Long-term Virologic Control of Perinatal Infection
Early antiretroviral therapy (ART) limits proviral reservoirs, a goal for human immunodeficiency virus type 1 (HIV-1) remission strategies. Whether this is an immediate or long-term effect of virologic suppression (VS) in perinatal infection is unknown.
We quantified HIV-1 DNA longitudinally for up to 14 years in peripheral blood mononuclear cells (PBMCs) among 61 perinatally HIV-1-infected youths in the Pediatric HIV/AIDS Cohort Study who achieved VS at different ages. Participants in group 1 (n = 13) were <1 year of age and in group 2 (n = 48) from 1 through 5 years of age at VS. Piecewise linear mixed-effects regression models assessed the effect of age at VS on HIV-1 DNA trajectories during VS.
In the first 2 years following VS, HIV-1 DNA levels decreased by -0.25 (95% confidence interval [CI], -.36 to -.13) log10 copies/million PBMCs per year and was faster with early VS by age 1 year compared with after age 1 (-0.50 and -0.15 log10 copies/million PBMCs per year, respectively). Between years 2 and 14 from VS, HIV-1 DNA decayed by -0.05 (95% CI, -.06 to -.03) log10 copies/million PBMCs per year and was no longer significantly different between groups. The estimated mean half-life of HIV-1 DNA from VS was 15.9 years and was shorter for group 1 compared to group 2 at 5.9 years and 18.8 years, respectively (P = .09). Adjusting for CD4 cell counts had no effect on decay estimates.
Early effective, long-term ART initiated from infancy leads to decay of HIV-1-infected cells to exceedingly low concentrations desired for HIV-1 remission strategies
- …